Suppr超能文献

从脂肪到FAT(CD36/SR-B2):理解细胞脂肪酸摄取的调控

From fat to FAT (CD36/SR-B2): Understanding the regulation of cellular fatty acid uptake.

作者信息

Glatz Jan F C, Luiken Joost J F P

机构信息

Department of Genetics & Cell Biology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, P.O. Box 616, 6200 MD Maastricht, The Netherlands.

Department of Genetics & Cell Biology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, P.O. Box 616, 6200 MD Maastricht, The Netherlands.

出版信息

Biochimie. 2017 May;136:21-26. doi: 10.1016/j.biochi.2016.12.007. Epub 2016 Dec 22.

Abstract

The molecular mechanisms underlying the cellular uptake of long-chain fatty acids and the regulation of this process have been elucidated in appreciable detail in the last decades. Two main players in this field, each discovered in the early 1990s, are (i) a membrane-associated protein first identified in adipose ('fat') tissue and referred to as putative fatty acid translocase (FAT)/CD36 (now officially designated as SR-B2) which facilitates the transport of fatty acids across the plasma membrane, and (ii) the family of transcription factors designated peroxisome proliferator-activated receptors (PPARα, PPARγ, and PPARβ/δ) for which fatty acids and fatty acid metabolites are the preferred ligand. CD36/SR-B2 is the predominant membrane protein involved in fatty acid uptake into intestinal enterocytes, adipocytes and cardiac and skeletal myocytes. The rate of cellular fatty acid uptake is regulated by the subcellular vesicular recycling of CD36/SR-B2 from endosomes to the plasma membrane. Fatty acid-induced activation of PPARs results in the upregulation of the expression of genes encoding various proteins and enzymes involved in cellular fatty acid utilization. Both CD36/SR-B2 and the PPARs have been implicated in the derangements in fatty acid and lipid metabolism occurring with the development of pathophysiological conditions, such as high fat diet-induced insulin resistance and diabetic cardiomyopathy, and have been suggested as targets for metabolic intervention. In this brief review we discuss the discovery and current understanding of both CD36/SR-B2 and the PPARs in metabolic homeostasis.

摘要

在过去几十年中,长链脂肪酸细胞摄取的分子机制及其调节过程已得到相当详细的阐明。该领域的两个主要参与者,均于20世纪90年代初被发现,分别是:(i)一种在脂肪组织中首次鉴定出的膜相关蛋白,被称为推定脂肪酸转运蛋白(FAT)/CD36(现正式命名为SR-B2),它促进脂肪酸跨质膜运输;(ii)过氧化物酶体增殖物激活受体家族(PPARα、PPARγ和PPARβ/δ),脂肪酸和脂肪酸代谢产物是其首选配体。CD36/SR-B2是参与脂肪酸摄取进入肠道肠上皮细胞、脂肪细胞以及心脏和骨骼肌细胞的主要膜蛋白。细胞脂肪酸摄取速率受CD36/SR-B2从内体到质膜的亚细胞囊泡循环调节。脂肪酸诱导的PPAR激活导致编码参与细胞脂肪酸利用的各种蛋白质和酶的基因表达上调。CD36/SR-B2和PPARs都与病理生理状况(如高脂饮食诱导的胰岛素抵抗和糖尿病性心肌病)发展过程中发生的脂肪酸和脂质代谢紊乱有关,并被建议作为代谢干预的靶点。在这篇简短的综述中,我们讨论了CD36/SR-B2和PPARs在代谢稳态中的发现及当前认识。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验